2025-04-02 - Analysis Report
## Chevron Corp (CVX) Stock Analysis

**0. Executive Summary:**

Chevron Corp (CVX) is an integrated energy company engaged in oil and gas exploration, production, refining, and marketing.  The analysis below examines CVX's performance against the S&P 500 (VOO), considering its recent price movements, financial indicators, and earnings data.  Overall, CVX shows a slightly underperformed compared to the S&P 500, but demonstrates strong financial health.

**1. Performance Comparison with S&P 500 (VOO):**

* **Cumulative Return (CVX):** 86.76%
* **Cumulative Return (VOO):** 89.44%
* **Return Difference:** -2.68%
* **Relative Divergence:** 51.3% (This indicates that the current underperformance is relatively mild compared to the historical range of divergence.)

The provided data shows that CVX has slightly underperformed the S&P 500 over the analyzed period.  The relative divergence suggests this underperformance is not extreme in a historical context.

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 34.0% | 8.3% | 16.0% | 0.2 | 161.5 |
| 2016-2018  | 12.0% | 9.8% | 5.0% | 0.0 | 145.8 |
| 2017-2019  | 3.0% | 9.8% | -16.0% | 0.2 | 168.0 |
| 2018-2020  | -38.0% | 21.1% | -72.0% | -0.2 | 124.4 |
| 2019-2021  | 15.0% | 21.1% | -58.0% | -0.4 | 181.9 |
| 2020-2022  | 81.0% | 57.9% | 70.0% | -0.5 | 288.3 |
| 2021-2023  | 71.0% | 57.9% | 53.0% | 0.1 | 249.0 |
| 2022-2024  | 11.0% | 57.9% | -11.0% | 0.4 | 252.2 |
| 2023-2025  | 1.0% | 55.6% | -40.0% | 0.4 | 296.7 |

The alpha values fluctuate significantly, indicating varying degrees of outperformance or underperformance relative to the market. The beta values generally hover around 0, suggesting relatively low market sensitivity.  However, the high volatility in alpha suggests that using a longer data range might give a more consistent picture of the stockâ€™s relative performance.


**2. Recent Price Movement:**

* **Closing Price:** $168.51
* **5-Day Moving Average:** $167.30
* **20-Day Moving Average:** $160.78
* **60-Day Moving Average:** $156.12

The price is above all three moving averages, suggesting an upward trend.  The relatively small difference between the closing price and the 5-day moving average implies a recent period of consolidation or minor increase.


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4382 (Medium Risk)
* **RSI:** 90.33 (Oversold)
* **PPO:** 0.3751 (Positive, suggesting upward momentum)
* **Recent (20-day) Relative Divergence Change:** +4.1% (Short-term upward trend)
* **Expected Return (vs. S&P 500, long-term):** 9.8%

The high RSI suggests the stock is overbought and may be due for a correction.  The positive PPO supports the upward momentum. However, these technical indicators should be evaluated within a broader context of fundamental analysis.  The relatively small daily price change, while positive, does not suggest a sharp upward move.  The long-term expected return is positive compared to the S&P 500.

**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-11-07 | 2.49 | $48.93 B     |
| 2024-08-07 | 2.43 | $49.57 B     |
| 2024-05-02 | 2.99 | $46.58 B     |
| 2023-11-02 | 3.48 | $51.92 B     |
| 2024-11-07 | 3.48 | $51.92 B     |

There's a duplicate entry for 2024-11-07.  Excluding the duplicate, the data shows some fluctuation in EPS and revenue.  A more detailed analysis would require a comparison to previous years' data and an understanding of the underlying factors driving these fluctuations.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue      | Profit Margin |
|---------|---------------|---------------|
| 2024-12-31 | $48.33B      | 27.34%        |
| 2024-09-30 | $48.93B      | 29.15%        |
| 2024-06-30 | $49.57B      | 29.66%        |
| 2024-03-31 | $46.58B      | 31.66%        |
| 2023-12-31 | $48.93B      | 29.02%        |

Revenue is relatively stable, while profit margins show some fluctuation, generally remaining strong.


**Capital and Profitability:**

| Quarter | Equity       | ROE           |
|---------|---------------|---------------|
| 2024-12-31 | $152.32B     | 2.13%         |
| 2024-09-30 | $156.20B     | 2.87%         |
| 2024-06-30 | $159.23B     | 2.78%         |
| 2024-03-31 | $160.62B     | 3.42%         |
| 2023-12-31 | $160.96B     | 1.40%         |

Equity shows a slight downward trend, while ROE fluctuates but remains within a reasonable range.


**6. Overall Conclusion:**

CVX demonstrates reasonably strong financial health, with consistent revenue and generally healthy profit margins.  However, its recent performance has slightly lagged the S&P 500.  Technical indicators suggest an overbought condition, indicating potential for a near-term correction. Despite the recent underperformance compared to the benchmark, the long-term expected return is promising.  Further investigation into the factors driving EPS and revenue fluctuations is needed for a more comprehensive assessment.  Considering the risk indicators and technical analysis, investors should monitor CVX closely for potential price volatility.
